We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Saluda Medical

News List

Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology prnasia
December 25, 2019
The results generated in the U.S. Evoke Pivotal Study demonstrate that the spinal cord response to stimulation can be successfully measured and used to adjust stimulation to maintain spinal cord activation within the patient-specific therapeutic window.
Saluda Medical announces European Commercial launch of Evoke biospectrumasia
September 17, 2019
Australia headquartered Saluda Medical Pty Limited has announced the award of CE Mark and the European commercial launch of the Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain.
Saluda Medical announces clinical study results of the chronic pain treatment biospectrumasia
June 03, 2019
The Evoke and Avalon studies both demonstrated improvements in pain, function, sleep, and quality of life